Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
1.
Z Rheumatol ; 78(8): 743-752, 2019 Oct.
Artículo en Alemán | MEDLINE | ID: mdl-31468168

RESUMEN

Rheumatoid arthritis, psoriatic arthritis and axial spondylarthritis are the most common chronic autoimmune rheumatic diseases. For all three diseases an early diagnosis and initiation of treatment is crucial. The proof of concept network study "Rheuma-VOR" is a further developed version of the predecessor project ADAPTHERA and was extended to several federal states. The aim of this prospective study is to improve the early diagnosis of rheumatoid arthritis, psoriatic arthritis and axial spondylarthritis and thus positively impact the quality of care for patients with the help of multidisciplinary coordinating centers. To date 3710 disease-specific questionnaires from patients with the suspected diagnosis of rheumatoid arthritis, psoriatic arthritis or axial spondylarthritis from 1298 different primary care providers were registered in the multidisciplinary coordination centers. A total of 1958 appointments were made with 1 of the 53 participating rheumatology specialists. In 876 patients, 1 of the 3 rheumatic diseases was diagnosed in an early stage. The waiting period was on average 42.5 days depending on the federal state, which is well below the nationwide average. It should also be noted that the coordinated cooperation and risk stratification of the Rheuma-VOR coordination centers relieved the capacity of rheumatology specialists by 1281 appointments (34.5%). In addition, the 2­week Rheuma Bus Tour and the accompanying initiatives in Rhineland-Palatinate (Rheuma-VOR screening app and the triage consultation) are showing first promising positive results.


Asunto(s)
Prestación Integrada de Atención de Salud/organización & administración , Enfermedades Reumáticas/diagnóstico , Reumatología , Artritis Psoriásica/diagnóstico , Artritis Reumatoide/diagnóstico , Prestación Integrada de Atención de Salud/normas , Diagnóstico Precoz , Humanos , Programas Nacionales de Salud , Estudios Prospectivos , Reumatología/organización & administración , Espondiloartritis/diagnóstico
2.
Eur J Clin Nutr ; 56(1): 72-81, 2002 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11840183

RESUMEN

OBJECTIVE: The objective of this study was to compare the effects of dietary monounsaturated fatty acids (MUFA), n-6 and n-3 polyunsaturated fatty acids (PUFA) on LDL composition and oxidizability. DESIGN, SETTING AND SUBJECTS: Sixty-nine healthy young volunteers, students at a nearby college, were included. Six subjects withdrew because of intercurrent illness and five withdrew because they were unable to comply with the dietary regimen. INTERVENTIONS: The participants received a 2-week wash-in diet rich in saturated fatty acids (SFA) followed by diets rich in refined olive oil, rapeseed oil or sunflower oil for 4 weeks. Intakes of vitamin E and other antioxidants did not differ significantly between the diets. RESULTS: At the end of the study, LDL oxidizability was lowest in the olive oil group (lag time: 72.6 min), intermediate in the rapeseed oil group (68.2 min) and highest in the sunflower oil group (60.4 min, P<0.05 for comparison of all three groups). Despite wide variations in SFA intake, the SFA content of LDL was not statistically different between the four diets (25.8-28.5% of LDL fatty acids). By contrast, the PUFA (43.5%-60.5% of LDL fatty acids) and MUFA content of LDL (13.7-29.1% of LDL fatty acids) showed a wider variability dependent on diet. CONCLUSIONS: Enrichment of LDL with MUFA reduces LDL susceptibility to oxidation. As seen on the rapeseed oil diet this effect is independent of a displacement of higher unsaturated fatty acids from LDL. Evidence from this diet also suggests that highly unsaturated n-3 fatty acids in moderate amounts do not increase LDL oxidizability when provided in the context of a diet rich in MUFA.


Asunto(s)
LDL-Colesterol/sangre , Grasas Insaturadas en la Dieta/administración & dosificación , Ácidos Grasos Monoinsaturados/administración & dosificación , Ácidos Grasos Insaturados/administración & dosificación , Aceites de Plantas/administración & dosificación , Tocoferoles/sangre , Triglicéridos/sangre , Adulto , Peso Corporal/fisiología , HDL-Colesterol/sangre , Registros de Dieta , Ingestión de Energía/fisiología , Femenino , Humanos , Masculino , Valores de Referencia
3.
Biochem Biophys Res Commun ; 288(2): 483-8, 2001 Oct 26.
Artículo en Inglés | MEDLINE | ID: mdl-11606068

RESUMEN

Here we report the induction of gene expression of ABCG4, a member of the ABC transporter subfamily G, from human macrophages by oxysterols and retinoids, agonists of the nuclear receptors LXR and RXR. The cloned ABCG4 transcript has a size of 3.5 kb and contains an open reading frame which encodes a polypeptide of 646 amino acids. Structurally, the putative ABC transporter protein consists of a nucleotide binding fold followed by a cluster of six transmembrane-spanning domains and thus conforms to the group of half-size ABC transporters. Among the human ABC transporter subfamily G members the novel transporter shows highest protein sequence homology and identity to ABCG1 (84 and 72%, respectively). Analysis of the genomic organization demonstrates that the ABCG4 gene is composed of at least 14 exons which extend across a region of 12.6 kb in size on chromosome 11q23.3. Based on its structural features and an LXR/RXR-responsive regulation similar to the cellular lipid export protein ABCA1, we conclude that ABCG4 may be involved in macrophage lipid homeostasis.


Asunto(s)
Transportadoras de Casetes de Unión a ATP/genética , Regulación de la Expresión Génica/efectos de los fármacos , Macrófagos/efectos de los fármacos , Retinoides/farmacología , Transportador de Casetes de Unión a ATP, Subfamilia G , Transportador de Casetes de Unión a ATP, Subfamilia G, Miembro 1 , Transportadoras de Casetes de Unión a ATP/química , Secuencia de Aminoácidos , Animales , Mapeo Cromosómico , Cromosomas Humanos Par 11 , Clonación Molecular , ADN Complementario/análisis , Exones , Genoma Humano , Humanos , Intrones , Macrófagos/fisiología , Ratones , Datos de Secuencia Molecular , Monocitos/fisiología , Homología de Secuencia de Aminoácido
5.
Thromb Res ; 101(5): 355-66, 2001 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-11297752

RESUMEN

High levels of fibrinogen, factor (F) VIIc, plasminogen activator inhibitor-1 (PAI-1), and plasma viscosity are associated with an increased coronary risk. As positive correlations of these parameters with triglycerides have been shown, the increased coronary risk associated with high levels of triglycerides may be assumed to be due to alterations within the hemostatic system. To reduce the coronary risk to which hypertriglyceridemic patients are exposed, dietary treatment is recommended; the optimal composition of such a diet is, however, a matter of debate. With regard to the effects on hemostasis, we compared in a sequential approach two diets for treatment of 25 nonobese male patients (age, mean+/-S.D., 40.4+/-8.7 years) with fasting triglycerides >2.3 mmol/l. The first diet (high fat) was rich in monounsaturated fatty acids (MUFA) and marine n-3 polyunsaturated fatty acids (PUFA), whereas the second diet (low-fat) was rich in complex carbohydrates and dietary fiber. The high-fat diet induced a significant lowering of FIIc, FIXc, FXc, FVIIc, FVIIa, FXIIa, PAI-1, plasma viscosity, and platelet activity, but led to an increase in fibrinogen, whereas the low-fat diet lowered FXIIc values and induced a nonsignificant decrease in fibrinogen. Probands on this diet had a slightly higher FVIIa and platelet activity than those on the high-fat diet. However, as all changes appeared to be within the normal range of each hemostatic parameter, it remains to be clarified whether the likely beneficial effects of the high-fat diet on most hemostatic factors are outweighed by the small increase in fibrinogen levels.


Asunto(s)
Dieta con Restricción de Grasas , Grasas Insaturadas en la Dieta/uso terapéutico , Ácidos Grasos Monoinsaturados/uso terapéutico , Ácidos Grasos Omega-3/uso terapéutico , Hemostasis , Hipertrigliceridemia/sangre , Hipertrigliceridemia/dietoterapia , Adulto , Factores de Coagulación Sanguínea/análisis , Índice de Masa Corporal , Colesterol/sangre , HDL-Colesterol/sangre , LDL-Colesterol/sangre , Grasas de la Dieta , Ácidos Grasos Monoinsaturados/administración & dosificación , Ácidos Grasos Omega-3/administración & dosificación , Ácidos Grasos Omega-6 , Ácidos Grasos Insaturados , Humanos , Masculino , Triglicéridos/sangre
6.
Thromb Haemost ; 85(2): 280-6, 2001 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11246548

RESUMEN

Various studies have already shown that the fatty acid composition of dietary fat has different effects on hemostasis and platelet function. However, knowledge on this topic is incomplete. In the present study, fifty-eight healthy students received either a 4-week rapeseed oil [high content of monounsaturated fatty acids (MUFA) and high n-3/n-6 PUFA ratio], an olive oil (high content of MUFA, low n-3/n-6 PUFA ratio) or a sunflower oil (low content of MUFA, low n-3/n-6 PUFA ratio) diet. In each group, effects on hemostatic parameters were compared with a wash-in diet rich in saturated fatty acids with respect to intermediate-time effects on the hemostatic system and platelet function. With the olive oil diet, a reduction of coagulation factors VIIc, XIIc, XIIa, and Xc was found, whereas sunflower oil led to lower values of coagulation factors XIIc, XIIa, and IXc. In all study groups levels of plasmin-alpha2-antiplasmin were lower in week 4 than at baseline. Lower fibrinogen binding on platelets was found after the sunflower oil diet, whereas expression of CD62 and spontaneous platelet aggregation were slightly higher after the olive oil diet. However, given the major differences in the fatty acid compositions of the diets, the differences between the groups with respect to hemostasis tended to be small. Therefore, the clinical significance of the present findings remains to be evaluated.


Asunto(s)
Grasas Insaturadas en la Dieta/farmacología , Hemostasis/efectos de los fármacos , Aceites de Plantas/farmacología , Adulto , Factor VII/efectos de los fármacos , Factor XII/efectos de los fármacos , Ácidos Grasos Monoinsaturados/farmacología , Ácidos Grasos Omega-3/farmacología , Ácidos Grasos Omega-6 , Ácidos Grasos Insaturados/farmacología , Femenino , Humanos , Masculino , Aceite de Oliva , Pruebas de Función Plaquetaria , Aceite de Brassica napus , Aceite de Girasol
7.
Int J Obes Relat Metab Disord ; 24(10): 1286-96, 2000 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-11093290

RESUMEN

BACKGROUND: There is lack of agreement on which dietary regimen is most suitable for treatment of hypertriglyceridemia, especially if high triglyceride concentrations are not due to obesity or alcohol abuse. We compared the effects on blood lipids of a diet high in total and unsaturated fat with a low-fat diet in patients with triglyceride concentrations of > 2.3 mmol/l. METHODS: Nineteen non-obese male outpatients with triglycerides ranging from 2.30 to 9.94 mmol/l received two consecutive diets for 3 weeks each: first a modified high-fat diet (39% total fat, 8% SFA, 15% monounsaturated fatty acids, 1.6% marine n-3 polyunsaturated fatty acids), and then a low-fat diet (total fat 28%, carbohydrates 54%). RESULTS: The high-fat diet significantly decreased triglycerides (-63%), total cholesterol (-22%), VLDL cholesterol (-54%), LDL cholesterol ( 16%), total apoC-III (-27%), apoC-III in apoB containing lipoproteins (apoC-III LpB; -31%) and in HDL (apoC-III nonLpB; -29%), apoE in serum (-33%) and apoB-containing lipoproteins (nonHDL-E; -42%), LpA-I (-16%), insulin (-36%), and leptin (-26%) and significantly increased the means of HDL cholesterol (+8%), LDL size (+6%), lipoprotein lipase (LPL, +11%), hepatic lipase (+13%), and lecithin: cholesterol acyltransferase (LCAT, +2%). The subsequent low-fat diet increased triglycerides (+63%), VLDL cholesterol (+19%), apoC-III (+23%), apoC-III LpB (+44%) apoC-III nonLpB (+17%), apoE (+29%) and nonHDL-E (+43%), and decreased HDL cholesterol (-12%), LPL (-3%), and LCAT (-3%). Changes in triglycerides correlated with changes in LPL activity and insulin levels. CONCLUSIONS: In hypertriglyceridemic patients, a modified diet rich in mono- and n-3 polyunsaturated fatty acids is more effective than a carbohydrate-rich low-fat diet in correcting the atherogenic lipoprotein phenotype.


Asunto(s)
Carbohidratos de la Dieta/administración & dosificación , Grasas Insaturadas en la Dieta/administración & dosificación , Ácidos Grasos Insaturados/administración & dosificación , Hipertrigliceridemia/dietoterapia , Lípidos/sangre , Lipoproteínas/sangre , Adulto , Biomarcadores , Proteínas Portadoras/sangre , Humanos , Insulina/sangre , Leptina/sangre , Lipasa/sangre , Lipoproteína Lipasa/sangre , Masculino , Persona de Mediana Edad , Factores de Tiempo , Resultado del Tratamiento , Triglicéridos/sangre
11.
J Biol Chem ; 269(33): 21277-83, 1994 Aug 19.
Artículo en Inglés | MEDLINE | ID: mdl-8063752

RESUMEN

Sterol carrier protein 2 (SCP2; also called nonspecific lipid transfer protein) is a small basic sterol carrier and lipid transfer protein assumed to participate in the intracellular transport of sterols and certain other lipids. Upon cloning and sequencing SCP2-encoding cDNAs, we and others found cDNAs containing unexpected in-frame 5'-extensions of up to 1,250 nucleotides upstream of the initiator ATG of the cDNA encoding pre-SCP2. The corresponding transcripts are primarily expressed in the liver and are predicted to encode a previously undescribed fusion protein containing a 143-amino acid C-terminal domain completely identical to pre-SCP2 and a 404-amino acid N-terminal domain with unknown biochemical activity or function (named sterol carrier protein x, SCPx). Here, we show that purified recombinant SCPx cleaves 3-oxoacyl(n)-CoA to yield acetyl-CoA and acyl(n-2)-CoA. Like SCP2, recombinant SCPx also stimulates the microsomal conversion of 7-dehydrocholesterol to cholesterol and transfers phosphatidylcholine and 7-dehydrocholesterol from small unilamellar vesicles to acceptor membranes in vitro. Furthermore, SCPx epitopes are primarily detected within peroxisomes. These findings suggest that SCPx is a previously undescribed peroxisomal 3-ketoacyl-CoA thiolase (EC 2.3.1.16) with intrinsic sterol carrier and lipid transfer activity (suggested name: SCP2/3-oxoacyl-CoA thiolase).


Asunto(s)
Acetil-CoA C-Acetiltransferasa , Acetil-CoA C-Aciltransferasa/metabolismo , Proteínas Portadoras/metabolismo , Metabolismo de los Lípidos , Microcuerpos/enzimología , Esteroles/metabolismo , Acetil-CoA C-Aciltransferasa/genética , Secuencia de Aminoácidos , Animales , Transporte Biológico , Proteínas Portadoras/genética , ADN Complementario , Humanos , Inmunohistoquímica , Hígado/enzimología , Datos de Secuencia Molecular , Fosfatidilcolinas/metabolismo , Ratas , Homología de Secuencia de Aminoácido
12.
Eur J Clin Nutr ; 48(3): 172-9, 1994 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-8194502

RESUMEN

OBJECTIVE: To investigate the effects of two kinds of decaffeinated coffee on serum lipid profiles in healthy young adults. DESIGN: Randomized controlled study with three study groups and a parallel design, consisting of two consecutive periods. SETTING: Outpatient clinical research center in a university clinic. SUBJECTS: 119 healthy students (60 male, 59 female) who were selected after a screening. All completed the study. Blood samples of three subjects (1 male, 2 female) were excluded from evaluation due to later diagnosed genetic anomalies of lipid metabolism. INTERVENTIONS: All subjects consumed 750-1000 ml of caffeinated filtered coffee per day for a 2 week wash-in period. During the 6 week test period one group continued drinking the caffeinated coffee, while the two other groups consumed different kinds of decaffeinated coffee. RESULTS: Consumption of both types of decaffeinated coffee did not lead to any significant changes in serum total and LDL cholesterol, triglycerides and apolipoprotein B. Furthermore, there were no significant differences in the reactions between the three groups. The diet did not change during the study. CONCLUSIONS: Switch from regular to decaffeinated coffee had no cholesterol-elevating effects, irrespective of the type of coffee.


Asunto(s)
Cafeína/farmacología , Colesterol/sangre , Café , Lipoproteínas/sangre , Triglicéridos/sangre , Adulto , Apolipoproteínas/análisis , Cafeína/administración & dosificación , Registros de Dieta , Femenino , Humanos , Masculino
13.
J Biol Chem ; 269(4): 2613-8, 1994 Jan 28.
Artículo en Inglés | MEDLINE | ID: mdl-8300590

RESUMEN

Recombinant human sterol carrier protein 2 (SCP2) variants were generated by site-directed mutagenesis and expression in Escherichia coli. The ability of the variants to stimulate microsomal conversion of 7-dehydrocholesterol to cholesterol (sterol carrier activity) and to transfer cholesterol and phosphatidylcholine from donor small unilamellar vesicles to acceptor membranes (cholesterol and phosphatidylcholine transfer activities) was compared with wild-type recombinant SCP2. Our results indicate that all measured activities of recombinant human pre-SCP2 (including the 20-amino acid leader sequence) and mature SCP2 were similar. Expressed glutathione S-transferase fusion proteins (GST-SCP2 and GST-pre-SCP2) possessed considerable activity, suggesting that steric obstruction at the amino terminus causes only minor inactivation. The effect of progressive removal of peptides from the carboxyl terminus showed that amino acids between Lys100 and Asn104 are essential for SCP2 activity. This conclusion was substantiated by the observation that replacing Asn104 with Asp or Ile caused considerable inactivation, whereas replacing Met105 with Leu had almost no effect. Since N-ethylmaleimide is known to inhibit SCP2 activity, substitutions were also introduced in the vicinity of Cys71. Whereas Val71 and Ser71 variants possessed wild-type activity, replacing Asp70 with Asn almost completely abolished SCP2 activity. Further, the importance of residues located close to the amino terminus was indicated by complete inactivation of a 10-amino-terminal amino acid deletion mutant and by replacing Leu20 with Glu. Circular dichroism results showed that Leu20 and Asp70 may serve to stabilize the overall fold, whereas residue 104 appears to play a role in the specific lipid binding and/or transfer activity of SCP2.


Asunto(s)
Proteínas Portadoras/metabolismo , Hígado/metabolismo , Proteínas de Plantas , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Proteínas Portadoras/biosíntesis , Proteínas Portadoras/química , Colesterol/metabolismo , Clonación Molecular , Secuencia de Consenso , Cartilla de ADN , ADN Complementario/metabolismo , Deshidrocolesteroles/metabolismo , Escherichia coli , Biblioteca de Genes , Humanos , Cinética , Liposomas , Datos de Secuencia Molecular , Mutagénesis Sitio-Dirigida , Fosfatidilcolinas/metabolismo , Reacción en Cadena de la Polimerasa , Estructura Secundaria de Proteína , Ratas , Proteínas Recombinantes/biosíntesis , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo , Homología de Secuencia de Aminoácido
14.
Am J Clin Nutr ; 56(4): 678-83, 1992 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-1414967

RESUMEN

This crossover study investigated the effects of two fat-reduced diets, one rich in monounsaturated fatty acids (MUFAs), the other rich in polyunsaturated fatty acids (PUFAs), on serum lipid profiles in 38 healthy young adults initially on a typical western diet. After being randomly assigned to two groups, the subjects received the MUFA or PUFA diet for 3-wk and then the other diet for 3 wk. Both test diets led to significant reductions in serum cholesterol, LDL cholesterol, and HDL cholesterol (P less than 0.001). Both reduced apolipoprotein B (P less than 0.001) and apolipoprotein A-I concentrations (P less than 0.01 for the MUFA, P less than 0.001 for the PUFA diet). Apolipoprotein A-I was significantly higher on the MUFA than on the PUFA diet. The ratio of apolipoprotein A-I to B significantly increased on both diets. Thus, a low-fat, MUFA-rich diet is as effective as a low-fat, PUFA-rich diet in lowering total and LDL cholesterol, but both also lowered HDL cholesterol concentrations. The MUFA-rich diet may be more advantageous than the PUFA-rich one because it does not lower apolipoprotein A-I concentrations as much as the PUFA-rich diet.


Asunto(s)
Grasas de la Dieta/administración & dosificación , Ácidos Grasos Monoinsaturados/administración & dosificación , Ácidos Grasos Insaturados/administración & dosificación , Lípidos/sangre , Adulto , Apolipoproteína A-I/metabolismo , Apolipoproteínas B/metabolismo , Colesterol/sangre , HDL-Colesterol/sangre , LDL-Colesterol/sangre , Femenino , Humanos , Masculino
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA